Apollo Hospitals
Revenue compounded at 15.6% annually over 10 years.
5 Healthcare companies — revenue, valuation and shareholding
Hospitals, diagnostics chains and medical-device makers. On Craytheon, 5 listed companies make up this sector, among them Apollo Hospitals, Fortis and Lal PathLabs (a predominantly small-cap group).
In focus: Apollo Hospitals · Fortis · Lal PathLabs · Indraprastha Medical
| Company | Revenue | YoY | Rev CAGR | P/E |
|---|---|---|---|---|
| Apollo Hospitals APOLLOHOSP | ₹21,994 Cr FY2025 | +14.8% | +15.6%10Y | 87.0 |
| Fortis FORTIS | ₹9,128 Cr FY2026 | +17.3% | +7.9%10Y | 68.7 |
| Lal PathLabs LALPATHLAB | ₹2,763 Cr FY2026 | +12.2% | +13.3%10Y | 58.3 |
| Poly Medicure POLYMED | ₹1,670 Cr FY2025 | +21.4% | +15.6%10Y | 48.8 |
| Indraprastha Medical INDRAMEDCO | ₹1,356 Cr FY2025 | +9% | +6.6%10Y | 20.8 |
Revenue, growth and P/E are from each company's latest filed year (FY labels can differ across companies). P/E is shown where derivable.
Missing a company in Healthcare?
We cover 500+ NSE-listed companies and keep expanding. Annual Plan members can request any company we don't list yet — sign up, send us the name, and we'll add it to our coverage.
Open any company for its full analysis — revenue trends, valuation models and shareholding.
Revenue compounded at 15.6% annually over 10 years.
Revenue of ₹2,763 Cr in FY2026.
Revenue grew 17.3% to ₹9,128 Cr in FY2026.
Revenue of ₹1,356 Cr in FY2025.
Revenue grew 21.4% to ₹1,670 Cr in FY2025.